Home » Topics » BioWorld Science

BioWorld Science
RSS

Nflection Therapeutics divulges new MAP2K1 inhibitors

June 12, 2020

USP48 found to be involved in hereditary hearing loss in animal model

June 12, 2020

ANGPT2 as novel diagnostic biomarker for primary lymphedema

June 12, 2020

Ausio Pharmaceuticals presents early clinical data for S-equol in TNBC

June 12, 2020

Qualigen and UofL to develop AS-1411 for the treatment of COVID-19

June 12, 2020

Phase II study of Leukine in recipients of haploidentical cell transplant

June 12, 2020

Namilumab and infliximab announced as first drugs to be evaluated in major COVID-19 trial

June 12, 2020

First patient with ovarian cancer dosed in second phase I study of Radspherin

June 12, 2020

Estrogen precursor drives breast cancer in obese postmenopausal women

June 12, 2020

Tychan initiates phase I trials with TY-027 for COVID-19

June 12, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...